Home Cart Sign in  
Chemical Structure| 213971-34-7 Chemical Structure| 213971-34-7

Structure of FX-11
CAS No.: 213971-34-7

Chemical Structure| 213971-34-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

FX-11 is a potent, selective, reversible, and competitive lactate dehydrogenase A (LDHA) inhibitor with a Ki of 8 μM. It reduces ATP levels, induces oxidative stress and ROS production, and promotes cell death. FX-11 shows antitumor activity in lymphoma and pancreatic cancer xenografts.

Synonyms: LDHA Inhibitor FX11

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of FX-11

CAS No. :213971-34-7
Formula : C22H22O4
M.W : 350.41
SMILES Code : CC1=CC2=C(C=C1CC3=CC=CC=C3)C(C(O)=O)=C(O)C(O)=C2CCC
Synonyms :
LDHA Inhibitor FX11
MDL No. :MFCD22572764

Safety of FX-11

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
DU145 0.25, 0.5, 1.5, 5, 15, 30, 60, 120, and 240 μM 24 hours To evaluate the effect of FX-11 on the proliferation of DU145 and PC3 cells, the results showed that the half maximal inhibitory concentration (IC50) for DU145 and PC3 cells was 32 ± 1.1 μmol/L and 27 ± 1.1 μmol/L, respectively. PMC7984723
PC3 0.25, 0.5, 1.5, 5, 15, 30, 60, 120, and 240 μM 24 hours To evaluate the effect of FX-11 on the proliferation of DU145 and PC3 cells, the results showed that the half maximal inhibitory concentration (IC50) for DU145 and PC3 cells was 32 ± 1.1 μmol/L and 27 ± 1.1 μmol/L, respectively. PMC7984723
MIN6 cells 25 µM 72 hours FX-11 significantly improved the survival rate of MIN6 cells under hypoxia and inhibited ROS production. PMC9496514
BxPc-3 49.27 µM 72 hours Evaluate the effect of FX-11 on BxPc-3 cell proliferation, results showed that FX-11 significantly inhibited cell proliferation PMC6770573
MIA PaCa-2 60.54 µM 72 hours Evaluate the effect of FX-11 on MIA PaCa-2 cell proliferation, results showed that FX-11 significantly inhibited cell proliferation PMC6770573
CD4+ T cells 20 μM FX-11 significantly reduced the production of IFN-γ and IL-17A without affecting cell viability. PMC11263433

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Male athymic Nude mice Prostate cancer xenograft model Intraperitoneal injection 42 μg/mouse/day Once daily for 5 consecutive days, for two weekly cycles To evaluate the effect of FX-11 on the growth of DU145 and PC3 xenografts, the results showed that FX-11 significantly inhibited the growth of DU145 tumors, while it had no significant effect on the growth of PC3 tumors. PMC7984723
CD-1 mice Subcutaneous BxPc3-Luc tumor model Intraperitoneal injection 2 mg/kg Once daily for 3 weeks Evaluate the effect of FX-11 on tumor growth in the subcutaneous BxPc3-Luc tumor model, results showed that FX-11 significantly delayed tumor growth PMC6770573

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.85mL

0.57mL

0.29mL

14.27mL

2.85mL

1.43mL

28.54mL

5.71mL

2.85mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories